Company that claims to be paving a new path from genes to therapeutic proteins using its messenger RNA technology platform
Ethris has raised €30M across 3 funding rounds from 3 investors, most recently a Grant round in May 2025. Based in Bayern, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-05-09 | Grant | €10M | EU4Health Grant | View deal → |
| 2024-06-18 | Other | €4.7M | The Bill & Melinda Gates Foundation | View deal → |
| 2023-01-03 | Other | €15M | Cipla EU | View deal → |
